Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
第一作者:
Hideo,Tanaka
第一单位:
Department of Hematology and Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. dtanaka@hiroshima-u.ac.jp
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);细胞凋亡(Apoptosis);碱基序列(Base Sequence);DNA引物(DNA Primers);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);人类(Humans);干扰素γ(Interferon-gamma);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);男(雄)性(Male);中年人(Middle Aged);中性白细胞(Neutrophils);聚合酶链反应(Polymerase Chain Reaction);RNA, 信使(RNA, Messenger);TNF相关凋亡诱导配体(TNF-Related Apoptosis-Inducing Ligand);增量调节(Up-Regulation)
DOI
10.1111/j.1600-0609.2007.00834.x
PMID
17432976
发布时间
2008-11-21
- 浏览13
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文